iPSC Market Overview
Induced pluripotent stem cell (iPSC) research has encapsulated a global market of scientists, clinicians, and investors and has quickly become the foundation for new regenerative medicines.
Quarterly Reports, White Papers
Locust Walk Insights, Market Trends, White Papers
Crossover Evolution: The Evolving Role of the Crossover Financing Round
The Covid-19 pandemic was the biggest biopharma news of 2020. It may be hard to remember now, but in March of last year, biotech indices had quickly nose-dived, along with the broader market, as the reality of the pandemic became apparent. The prevailing financial sentiment was doom and gloom.
News
Boston Business Journal: Life sciences firm Locust Walk’s plans for its $175M SPAC
Geoff Meyerson co-founded Locust Walk, a Boston-based life sciences consulting firm, on Sept. 15, 2008, the same day that Lehman Brothers filed for bankruptcy and Merrill Lynch sold itself to Bank of America.
Market Conditions, Market Trends, News, Quarterly Reports
2020 Year-In-Review Report: Global Trends in Biopharma Transactions
Each quarter our team at Locust Walk compiles key statistics and trends on strategic transactions and financings. Our 2020 Year End Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life science deal landscape.
Capital Raising, Market Trends, News, White Papers
Doubling Down: The Power of Asset Diversification in a Time of Robust Access to Capital
Following up on our recent white paper, Biopharma’s COVID Capital Comeback, here is a look at the greatest risk facing public biopharma companies — single asset failures — and what they can do during this time of robust capital.
Locust Walk Insights
Q3 2020 Report: Global Trends in Biopharma Transactions
Q3 2020 Report: Global Trends in Biopharma Transactions Each quarter our team at Locust Walk compiles key statistics and trends on strategic
Uncategorized
Panel Recording! Knocking At The Door: Challenges Women Face With Biopharma Boards
BIO (Biotech Innovation Organization) collected a survey in January of 2020 to better understand the current demographics of biopharma companies. Responses to their questions on representation indicate that the number of women decreases at higher levels.
Capital Markets
Biopharma’s COVID Capital Comeback
Biopharma’s COVID Capital Comeback What a difference a few months can make – especially during a pandemic. Heading into 2020,
Capital Markets, Capital Raising, Market Trends, White Papers
Biopharma’s COVID Capital Comeback – A Whitepaper
Heading into 2020, biopharma looked like it would be typecast in its typical election year role: the big business scapegoat for everything that’s wrong in health care. There had been the usual big Phase 3 trial failures.
Capital Markets, News
Panel Recording: The Unexpected IPO Boom in Biopharma in Q2
CATEGORIES News Events Publications ARCHIVE Panel Recording: The Unexpected IPO Boom in Biopharma in Q2 Locust Walk partnered with Applied